TOI

Oncology Institute Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 6/10
  • Value↓ 4/10
Oncology Institute sales and earnings growth
TOI Growth
Good
  • Revenue Y/Y↑ 27.79%
  • EPS Y/Y↑ 5.09%
  • FCF Y/Y↑ 8.38%
Oncology Institute gross and profit margin trends
TOI Profitability
Neutral
  • Gross margin ↑ 15.20%
  • EPS margin↓ -12.10%
  • ROIC 5Y↓ -28.84%
Oncology Institute net debt vs free cash flow
TOI Risk
Poor
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 2.5
  • Interest coverage↓ -4.4

Oncology Institute stock volatility is higher than the overall market. We give it a Poor risk rating.

More Medical Care Facilities stocks ↗